IBBR Publications

Found 16 results
Filters: Keyword is Neoplasms  [Clear All Filters]
2017
Chowdhury A, Brinson RG, Wei B, Stetler-Stevenson WG. Tissue Inhibitor of Metalloprotease-2 (TIMP-2): Bioprocess Development, Physicochemical, Biochemical, and Biological Characterization of Highly Expressed Recombinant Protein. Biochemistry. 2017 ;56(49):6423-6433.
2016
Astudillo L, Da Silva TG, Wang Z, Han X, Jin K, VanWye J, Zhu X, Weaver K, Oashi T, Lopes PEM, et al. The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis. Cancer Res. 2016 ;76(12):3593-603.
2013
S Hasan S, Rizvi A, Naseem I. Calcitriol-induced DNA damage: toward a molecular mechanism of selective cell death. IUBMB Life. 2013 ;65(9):787-92.
Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, Geczy CL. Functions of S100 proteins. Curr Mol Med. 2013 ;13(1):24-57.
Rizvi A, S Hasan S, Naseem I. Selective cytotoxic action and DNA damage by calcitriol-Cu(II) interaction: putative mechanism of cancer prevention. PLoS One. 2013 ;8(9):e76191.
2011
Yap JL, Worlikar S, Mackerell AD, Shapiro P, Fletcher S. Small-molecule inhibitors of the ERK signaling pathway: Towards novel anticancer therapeutics. ChemMedChem. 2011 ;6(1):38-48.
2010
Swanson HI, Njar VCO, Yu Z, Castro DJ, Gonzalez FJ, Williams DE, Huang Y, Kong A-NT, Doloff JC, Ma J, et al. Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy. Drug Metab Dispos. 2010 ;38(4):539-44.
2008
Sofou S, Y Yu B. Delivery systems for the targeted radiotherapy of cancer. Preface. Adv Drug Deliv Rev. 2008 ;60(12):1317-8.
2007
S Hasan S, Ashraf GMd, Banu N. Galectins - potential targets for cancer therapy. Cancer Lett. 2007 ;253(1):25-33.
Markowitz J, Mackerell AD, Weber DJ. A search for inhibitors of S100B, a member of the S100 family of calcium-binding proteins. Mini Rev Med Chem. 2007 ;7(6):609-16.
Chao KL, Muthukumar L, Herzberg O. Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis. Biochemistry. 2007 ;46(23):6911-20.
Bruno RD, Njar VCO. Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg Med Chem. 2007 ;15(15):5047-60.
Sundberg EJ, Deng L, Mariuzza RA. TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol. 2007 ;19(4):262-71.
2006
Njar VCO, Gediya L, Purushottamachar P, Chopra P, Vasaitis TSean, Khandelwal A, Mehta J, Huynh C, Belosay A, Patel J. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg Med Chem. 2006 ;14(13):4323-40.
Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem. 2006 ;281(2):677-80.
1992
Stancovski I, Peles E, Ben Levy R, Lemprecht R, Kelman Z, Goldman-Michael R, Hurwitz E, Bacus S, Sela M, Yarden Y. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy. J Steroid Biochem Mol Biol. 1992 ;43(1-3):95-103.